SCHEMBL5780286

SCHEMBL5780286

O=Cc1c[nH]nc1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.44
AR P10275 1/20 0.44
HPGD P15428 4/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP2C9 P11712 2/20 0.42
LTB4R Q15722 1/20 0.39
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CALM1 P0DP23 1/20 0.38
DAO P14920 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MPO P05164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28224204 0.80 ALDH1A1 (0.46) ALDH1A1CYP2C9KDM4EMEN1LMNA
SCHEMBL15093846 0.79 AR (0.48) ARALDH1A1HTTKDM4EDAO
SCHEMBL5776720 0.79 AR (0.48) ARALDH1A1HTTKDM4EDAO
SCHEMBL28815309 0.77 KMT2A (0.36) HPGDALDH1A1CYP2C9HTTDAO
SCHEMBL27629487 0.76 PARP1 (0.43) PARP1ARHPGDALDH1A1CYP2C9
SCHEMBL15565201 0.74 LTB4R (0.49) PARP1ARHPGDALDH1A1CYP2C9
SCHEMBL4442119 0.74 PARP1 (0.42) PARP1ARHPGDALDH1A1CYP2C9
SCHEMBL22547317 0.74 PARP1 (0.42) PARP1ARHPGDALDH1A1CYP2C9
SCHEMBL7458172 0.74 PARP1 (0.45) PARP1ARHPGDALDH1A1CYP2C9
SCHEMBL578238 0.74 LIPE (0.41) PARP1ARHPGDALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-07-12 EP disclosed
WO-2005042534-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2005-05-12 WO disclosed